Serum concentration of interleukin 6 is related to inflammation and dyslipidemia in patients with psoriasis.

Introduction: Patients with psoriasis and psoriatic arthritis (PsA) have metabolic disturbances, which may be due to chronic inflammation.

Aim: Because interleukin-6 (IL-6) regulates both metabolic and inflammatory processes, we evaluated IL-6 as a potential marker of inflammation and metabolic disturbances in psoriasis.

Material And Methods: This study involved 93 patients with psoriasis, including 31 patients with concurrent PsA.